Transcriptome Profiling Reveals the Endogenous Sponging Role of LINC00659 and UST-AS1 in High-Altitude Induced ThrombosisFunding This study was funded by Defense Research and Development Organization (DRDO), India, under the project SLT-09/DIP-255.
Background The pathophysiology of deep vein thrombosis (DVT) is considered as multifactorial, where thrombus formation is an interplay of genetic and acquired risk factors. Little is known about the expression profile and roles of long noncoding RNAs (lncRNAs) in human subjects developing DVT at high altitude.
Methods Using RNAseQ, we compared peripheral blood mRNA and lncRNA expression profile in human high-altitude DVT (HA-DVT) patients with high-altitude control subjects. We used DESeq to identify differentially expressed (DE) genes. We annotated the lncRNAs using NONCODE 3.0 database. In silico putative lncRNA–miRNA association study unravels the endogenous miRNA sponge associated with our candidate lncRNAs. These findings were validated by small-interfering RNA (siRNA) knockdown assay of the candidate lncRNAs conducted in primary endothelial cells.
Results We identified 1,524 DE mRNAs and 973 DE lncRNAs. Co-expressed protein-coding gene analysis resulted in a list of 722 co-expressed protein-coding genes with a Pearson correlation coefficients >0.7. The functional annotation of co-expressed genes and putative proteins revealed their involvement in the hypoxia, immune response, and coagulation cascade. Through its miRNA response elements to compete for miR-143 and miR-15, lncRNA-LINC00659 and UXT-AS1 regulate the expression of prothrombotic genes. Furthermore, in vitro RNA interference (siRNA) simultaneously suppressed lncRNAs and target gene mRNA level.
Conclusion This transcriptome profile describes novel potential mechanisms of interaction between lncRNAs, the coding genes, miRNAs, and regulatory transcription factors that define the thrombotic signature and may be used in establishing lncRNAs as a biomarker in HA-DVT.
P.K.J. and A.V. performed the experiments, analyzed the data, and wrote the manuscript; A.P., T.C., N.B., and V.N. participated in the clinical part of the study; B.K. edited the manuscript; M.S. and M.Z.A. designed the study and edited the manuscript.
* Present address: Department of Biotechnology, Jamia Millia Islamia, New Delhi110025, India.
Eingereicht: 30. Oktober 2020
Angenommen: 09. Februar 2021
12. Februar 2021 (online)
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Pandey P, Lohani B, Murphy H. Pulmonary embolism masquerading as high altitude pulmonary edema at high altitude. High Alt Med Biol 2016; 17 (04) 353-358
- 2 Gupta N, Sahu A, Prabhakar A. et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc Natl Acad Sci U S A 2017; 114 (18) 4763-4768
- 3 Jha PK, Sahu A, Prabhakar A. et al. Genome-wide expression analysis suggests hypoxia-triggered hyper-coagulation leading to venous thrombosis at high altitude. Thromb Haemost 2018; 118 (07) 1279-1295
- 4 Prabhakar A, Chatterjee T, Bajaj N. et al. Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains. Blood Adv 2019; 3 (22) 3713-3723
- 5 Choudhry H, Mole DR. Hypoxic regulation of the noncoding genome and NEAT1. Brief Funct Genomics 2016; 15 (03) 174-185
- 6 Samani NJ, Erdmann J, Hall AS. et al; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357 (05) 443-453
- 7 Michalik KM, You X, Manavski Y. et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014; 114 (09) 1389-1397
- 8 Cabili MN, Trapnell C, Goff L. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25 (18) 1915-1927
- 9 Derrien T, Johnson R, Bussotti G. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22 (09) 1775-1789
- 10 Paralikar SJ, Paralikar JH. High-altitude medicine. Indian J Occup Environ Med 2010; 14 (01) 6-12
- 11 Hansen TB, Jensen TI, Clausen BH. et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495 (7441): 384-388
- 12 Carpenter S, Aiello D, Atianand MK. et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013; 341 (6147): 789-792
- 13 Gupta RA, Shah N, Wang KC. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464 (7291): 1071-1076
- 14 Han P, Li W, Lin CH. et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 2014; 514 (7520): 102-106
- 15 Lorenzen JM, Schauerte C, Kielstein JT. et al. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin Chem 2015; 61 (01) 191-201
- 16 Zhao Z, Bai J, Wu A. et al. Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data. Database (Oxford) 2015; 2015: bav082
- 17 Golja P, Flander P, Klemenc M, Maver J, Princi T. Carbohydrate ingestion improves oxygen delivery in acute hypoxia. High Alt Med Biol 2008; 9 (01) 53-62
- 18 Heinonen IH, Boushel R, Kalliokoski KK. The circulatory and metabolic responses to hypoxia in humans - with special reference to adipose tissue physiology and obesity. Front Endocrinol (Lausanne) 2016; 7: 116
- 19 Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985) 2009; 106 (05) 1538-1544
- 20 Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001; 276 (11) 7919-7926
- 21 Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003; 23 (01) 359-369
- 22 Ortmann B, Druker J, Rocha S. Cell cycle progression in response to oxygen levels. Cell Mol Life Sci 2014; 71 (18) 3569-3582
- 23 Björkqvist J, Jämsä A, Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013; 110 (03) 399-407
- 24 Zhang X, Wang Q, Shen Y, Song H, Gong Z, Wang L. Compromised natural killer cells in pulmonary embolism. Int J Clin Exp Pathol 2015; 8 (07) 8244-8251
- 25 Buil A, Trégouët DA, Souto JC. et al. C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 2010; 115 (23) 4644-4650
- 26 Sheng Y, Han C, Yang Y. et al. Correlation between LncRNA-LINC00659 and clinical prognosis in gastric cancer and study on its biological mechanism. J Cell Mol Med 2020; 24 (24) 14467-14480
- 27 Tsai KW, Lo YH, Liu H. et al. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer 2018; 17 (01) 72
- 28 Li YD, Ye BQ, Zheng SX. et al. NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem 2009; 284 (07) 4473-4483
- 29 Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?. J Clin Invest 2000; 106 (06) 733-738
- 30 Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood 2014; 124 (13) 2013-2024
- 31 Li A, Ge M, Zhang Y, Peng C, Wang M. Predicting long noncoding RNA and protein interactions using heterogeneous network model. BioMed Res Int 2015; 2015: 671950
- 32 Suravajhala P, Kogelman LJ, Mazzoni G, Kadarmideen HN. Potential role of lncRNA cyp2c91-protein interactions on diseases of the immune system. Front Genet 2015; 6: 255
- 33 Dickinson J, Heath D, Gosney J, Williams D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax 1983; 38 (09) 646-656
- 34 Higgins JP, Tuttle T, Higgins JA. Altitude and the heart: is going high safe for your cardiac patient?. Am Heart J 2010; 159 (01) 25-32
- 35 Song SY, Asaji T, Tanizaki Y, Fujimaki T, Matsutani M, Okeda R. Cerebral thrombosis at altitude: its pathogenesis and the problems of prevention and treatment. Aviat Space Environ Med 1986; 57 (01) 71-76
- 36 Van Os E, Wu YP, Pouwels JG. et al. Thrombopoietin increases platelet adhesion under flow and decreases rolling. Br J Haematol 2003; 121 (03) 482-490
- 37 Vassbotn FS, Havnen OK, Heldin CH, Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J Biol Chem 1994; 269 (19) 13874-13879
- 38 Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther 2016; 99 (05) 494-501
- 39 Kataoka M, Wang DZ. Non-coding RNAs including miRNAs and lncRNAs in cardiovascular biology and disease. Cells 2014; 3 (03) 883-898
- 40 Li N, Ponnusamy M, Li MP, Wang K, Li PF. The role of MicroRNA and LncRNA-MicroRNA interactions in regulating ischemic heart disease. J Cardiovasc Pharmacol Ther 2017; 22 (02) 105-111
- 41 Wang J, Liu X, Wu H. et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38 (16) 5366-5383
- 42 Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10 (10) 1507-1517
- 43 Shi R, Zhou X, Ji WJ. et al. The emerging role of miR-223 in platelet reactivity: implications in antiplatelet therapy. BioMed Res Int 2015; 2015: 981841
- 44 Uchiyama T, Kurabayashi M, Ohyama Y. et al. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20 (04) 1155-1161